| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |